8-K: Unicycive Therapeutics Announces Time Change for 2025 Annual Meeting of Stockholders
8-K Filing
Unicycive Therapeutics announced a change in the time of its 2025 Annual Meeting of Stockholders, while the date and location remain the same.
Summary
- Unicycive Therapeutics announced a change in the time of the 2025 Annual Meeting of Stockholders.
- The meeting will still be held on June 9, 2025, at 4300 El Camino Real, Suite 210, Los Altos, CA 94022.
- However, the time has been changed to 7:00 a.m., Pacific Daylight Time.
- Stockholders of record as of April 30, 2025, can find additional details regarding participation in the Annual Meeting.
Sentiment
Score: 5
Explanation: The announcement is neutral, simply conveying a change in the time of the annual meeting.
Future Outlook
The document does not contain any specific forward-looking statements regarding financial performance or business outlook beyond the details of the Annual Meeting.
Industry Context
This announcement is a routine update regarding corporate governance and shareholder meetings, common for publicly traded companies in the biotechnology sector.
Stakeholder Impact
- Shareholders need to be aware of the time change for the Annual Meeting to participate.
Next Steps
- Stockholders should note the new time for the Annual Meeting.
- Stockholders can find additional details regarding participation in the Annual Meeting.
Key Dates
| Date | Description |
|---|---|
| 2025-04-30 | Record date for stockholders eligible to participate in the Annual Meeting. |
| 2025-05-21 | Date of the announcement regarding the time change for the Annual Meeting. |
| 2025-06-09 | Date of the Annual Meeting of Stockholders, now scheduled for 7:00 a.m. Pacific Daylight Time. |
Keywords
Annual Meeting, Stockholders, Unicycive Therapeutics, Time Change, Kidney Disease, Biotechnology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.